课题基金 / 基金详情

H HEPATICUS--PATHOGENESIS OF INFLAMMATORY BOWEL DISEASE

H HEPATICUS--PATHOGENESIS OF INFLAMMATORY BOWEL DISEASE
肝螺杆菌——炎症性肠病的发病机制
批准号:
6138054
负责人:
DAVID B SCHAUER
金额:
$26.7万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-01-01 至 2002-12-31

项目摘要

项目成果

DAVID B SCHAUER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from the applicant's abstract): The human inflammatory bowel diseases (IBDs), Crohn's disease and ulcerative colitis, are multifactorial disorders whose etiology remains unknown. Animal models have been developed to help understand the complex interaction between the immune system and intestinal antigens - particularly bacteria - which appear to be involved in the pathogenesis of disease. Infection with the mouse pathogen Helicobacter hepaticus has been associated with disease in mice which are genetically and/or immunologically predisposed to the development of IBD. H. hepaticus, like the human gastroduodenal pathogen H. pylori, expresses putative virulence factors which may contribute to chronic mucosal inflammation, epithelial cell proliferation, and an increased risk for cancer. The investigators propose to test the hypothesis that infection with H. hepaticus is sufficient for expression of disease in mice which are predisposed to the development of IBD. They also propose to identify the bacterial virulence factors of H. hepaticus which are involved in the pathogenesis of IBD in the mouse models. These studies will characterize the mechanism by which infection with a single bacterial species can affect expression of disease in mouse models of IBD. It is hoped that these studies will lead to the development of rational therapy for patients suffering from Crohn's disease and ulcerative colitis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
In Vivo Role of Nitric Oxide in Muscosal Inflammation and Cancer
Core--Environmental Systems and Health Research
In Vivo Role of NO in Mucosal Inflammation and Cancer
H HEPATICUS--PATHOGENESIS OF INFLAMMATORY BOWEL DISEASE
国内基金
海外基金
高脂饮食诱导肠道微生物Helicobacter促进肠癌发生的分子机制研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    55.7万元
  • 批准年份:
    2021
  • 负责人:
    朱亚辉
  • 依托单位:
研发纳米金材料改良免疫探测器用于定量分析污水中幽门螺旋杆菌(Helicobacter pylori, Hp)的新型流行病学研究
  • 批准号:
    LQ22B050004
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    卢鼎南
  • 依托单位:
肥胖对Helicobacter suis感染后胃MALT淋巴瘤发生的影响及其炎性机制的研究
  • 批准号:
    81572320
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2015
  • 负责人:
    杨林
  • 依托单位: